Cargando…
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States
BACKGROUND: The inclusion of patent linkage mechanisms in bilateral and plurilateral trade and investment agreements has emerged as a key element in the United States’ TRIPS-Plus intellectual property (IP) negotiating agenda. However, the provisions establishing patent linkage mechanisms in several...
Autores principales: | Son, Kyung-Bok, Lopert, Ruth, Gleeson, Deborah, Lee, Tae-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201583/ https://www.ncbi.nlm.nih.gov/pubmed/30355313 http://dx.doi.org/10.1186/s12992-018-0423-0 |
Ejemplares similares
-
Patenting and patent challenges in South Korea after introducing a patent linkage system
por: Son, Kyung-Bok
Publicado: (2022) -
Patent challenges and factors associated with successful patent challengers under the patent linkage system: recent evidence from South Korea after the Korea United States free trade agreement
por: Son, Kyung-Bok, et al.
Publicado: (2021) -
Perceived impact of the patent linkage system on pharmaceutical market from the viewpoint of the domestic manufacturers in South Korea
por: Choi, Nahye, et al.
Publicado: (2022) -
'Linkage' pharmaceutical evergreening in Canada and Australia
por: Faunce, Thomas A, et al.
Publicado: (2007) -
The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries
por: Gleeson, Deborah, et al.
Publicado: (2017)